The Latest Breaking News from Wedbush

"Apple and Cook are in a position to gain market share and hire talent," Wedbush Securities analyst Dan Ives says.

Marketing is one of McDonald's "primary competitive edges," says Wedbush analyst Nick Setyan.

Apellis Pharmaceuticals’ (APLS) stock has jumped more than 25% year-to-date based on FDA approval for treating geographic atrophy. Despite the breakthrough, the company’s ability to scale up production remains a concern. Moreover, its closest competitor is also close to getting approval. Given its poor financials, stretched valuation, and weak profitability,…

Tech companies are racing to figure out how to implement A.I. in their products, and it’s not just about search engines.

The billionaire entrepreneur said it’s unlikely he’ll be able to choose a suitable successor to run the ailing social media platform until the end of 2023.

Tesla stock advanced for eight straight days and gained 68% on the year until Friday. Analysts are signaling the run could end.

Tesla marched higher as data Wednesday shows 59% of its China-made vehicles in January were exported.

Tesla has gained 91% since Jan. 6 bear-market lows, but this Tesla bull just hiked his stock price target.

“There is a window of opportunity to gain share...and 2023 is a pivotal year that will establish the winners and losers in this EV landscape,” Wedbush tech analyst Dan Ives says amid the industry's price cuts.